BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 11755652)

  • 1. Polyneuropathy in type 2 diabetes mellitus.
    Engel WK
    Lancet; 2001 Dec; 358(9298):2086. PubMed ID: 11755652
    [No Abstract]   [Full Text] [Related]  

  • 2. Intravenous immunoglobulin G is remarkably beneficial in chronic immune dysschwannian/dysneuronal polyneuropathy, diabetes-2 neuropathy, and potentially in severe acute respiratory syndrome.
    Engel WK
    Acta Myol; 2003 Dec; 22(3):97-103. PubMed ID: 15088499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bilateral phrenic neuropathies in a diabetic patient responsive to intravenous immunoglobulin: a case report.
    Rison RA; Beydoun SR
    Clin Neurol Neurosurg; 2011 Nov; 113(9):788-91. PubMed ID: 21906870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human immunoglobulin for diabetic amyotrophy--a promising prospect?
    Courtney AE; McDonnell GV; Patterson VH
    Postgrad Med J; 2001 May; 77(907):326-8. PubMed ID: 11320277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An unusual neuropathy in a diabetic patient: evidence for intravenous immunoglobin-induced effective therapy.
    Romedenne P; Mukendi R; Stasse P; Indekeu P; Buysschaert M; Colin IM
    Diabetes Metab; 2001 Apr; 27(2 Pt 1):155-8. PubMed ID: 11353882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diabetic amyotrophy or proximal diabetic neuropathy an immune-mediated condition?
    Baba M
    Intern Med; 2001 Apr; 40(4):273-4. PubMed ID: 11334383
    [No Abstract]   [Full Text] [Related]  

  • 7. Diabetic lumbosacral radiculoplexus neuropathy succesfully treated with intravenous immunoglobulins.
    López Ruiz R; Quintas Gutiérrez S; Zapata-Wainberg G
    Med Clin (Barc); 2018 Jun; 150(11):452-453. PubMed ID: 29179890
    [No Abstract]   [Full Text] [Related]  

  • 8. Intravenous immunoglobulin therapy for diabetic amyotrophy.
    Ogawa T; Taguchi T; Tanaka Y; Ikeguchi K; Nakano I
    Intern Med; 2001 Apr; 40(4):349-52. PubMed ID: 11334398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-Dose Intravenous Immunoglobulin Is Effective Diabetic Polyneuropathy Resistant to Conventional Treatments. Results of a Double-Blind, Randomized, Placebo-Controlled Trial: Comments.
    Wee TC; Tan YL
    Pain Med; 2020 Oct; 21(10):2603-2604. PubMed ID: 32196108
    [No Abstract]   [Full Text] [Related]  

  • 10. [Rapidly evolving diabetic mononeuritis multiplex. Favorable outcome after immunosuppressive treatment].
    Awada A; Dehoux E; al Jumah M; al Ayafi H
    Rev Neurol (Paris); 2001 Nov; 157(11 Pt 1):1427-9. PubMed ID: 11924012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A case of diabetic amyotrophy with severe atrophy and weakness of shoulder girdle muscles showing good response to intravenous immune globulin.
    Wada Y; Yanagihara C; Nishimura Y; Oka N
    Diabetes Res Clin Pract; 2007 Jan; 75(1):107-10. PubMed ID: 16781792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diabetic polyneuropathy and glucose control.
    Finucane TE
    JAMA; 2010 Feb; 303(5):420; author reply 420-1. PubMed ID: 20124535
    [No Abstract]   [Full Text] [Related]  

  • 13. CIDP variants in diabetes: measuring treatment response with a small nerve fiber test.
    Névoret ML; Vinik AI
    J Diabetes Complications; 2015 Mar; 29(2):313-7. PubMed ID: 25466645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term response of neuropathic pain to intravenous immunoglobulin in relapsing diabetic lumbosacral radiculoplexus neuropathy. A case report.
    Tamburin S; Magrinelli F; Favaro F; Briani C; Zanette G
    Pain Pract; 2014 Feb; 14(2):E85-90. PubMed ID: 24152254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential response to intravenous immunoglobulin (IVIg) therapy among multifocal and polyneuropathy types of painful diabetic neuropathy.
    Kawagashira Y; Watanabe H; Morozumi S; Iijima I; Koike H; Hattori N; Sobue G
    J Clin Neurosci; 2010 Aug; 17(8):1003-8. PubMed ID: 20627580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Diabetic neuropathies].
    Azulay JP; Pouget J
    Rev Prat; 2001 Oct; 51(16):1783-7. PubMed ID: 11795122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous immunoglobulin as first treatment in diabetics with concomitant distal symmetric axonal polyneuropathy and CIDP.
    Cocito D; Ciaramitaro P; Isoardo G; Barbero P; Migliaretti G; Pipieri A; Proto G; Quadri R; Bergamasco B; Durelli L
    J Neurol; 2002 Jun; 249(6):719-22. PubMed ID: 12111305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diabetic amyotrophy in an adolescent responsive to intravenous immunoglobulin.
    Fernandes Filho JA; Nathan BM; Palmert MR; Katirji B
    Muscle Nerve; 2005 Dec; 32(6):818-20. PubMed ID: 15991252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic inflammatory demyelinating polyneuropathy in a diabetic patient: deterioration after intravenous immunoglobulins treatment and favorable response to steroid treatment.
    Pedersen K; Pandolfo M; Mavroudakis N
    Acta Neurol Belg; 2007 Mar; 107(1):14-7. PubMed ID: 17569228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Efficiency of cerebrolysin in the diabetic polyneuropathy in patients with insulin-dependency diabetes mellitus].
    Bogdanov EI; Sakovets TG
    Zh Nevrol Psikhiatr Im S S Korsakova; 2011; 111(2):35-9. PubMed ID: 21350421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.